Fidelity Investments’s Avalyn Pharma AVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$176M Buy
6,185,994
+350,735
+6% +$11.3M 0.01% 985
2026
Q2
$192M Buy
+5,835,259
New +$168M 0.01% 942

Other funds holding AVLN

Fidelity Investments's AVLN Position: Q3 2026 in Review

Fidelity Investments increased its Avalyn Pharma (AVLN) stake by 6% in Q3 2026, buying an estimated $11.3M and bringing the position to 6,185,994 shares worth $176M. The position accounts for 0.01% of the portfolio, ranked #985.

Fidelity Investments first reported a position in AVLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $192M in Q2 2026. 116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • Fidelity Investments held 6,185,994 shares of Avalyn Pharma worth $176M as of Q3 2026.
  • Fidelity Investments bought 350,735 Avalyn Pharma shares in Q3 2026, an estimated $11.3M.
  • Avalyn Pharma made up 0.01% of Fidelity Investments's portfolio in Q3 2026, its #985 holding.
  • Fidelity Investments first reported a position in Avalyn Pharma in Q2 2026 and has held it in 2 quarters since.
  • Fidelity Investments's Avalyn Pharma position peaked at $192M in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.